Australian Supplement Industry Statistics (2026): Market Size, Trends & Consumer Insights
, 31 min reading time
, 31 min reading time
Australia has quietly become one of the most supplement-hungry nations on earth. Walk into any pharmacy, health food store, or open a browser tab and the breadth of options, from collagen powders and probiotic capsules to plant-based protein bars and adaptogenic mushroom blends, tells a story of a country that has gone all-in on preventive health.
This page brings together the most important data points on the Australian supplement, health food, and wellness industry in one place. Whether you are a health-conscious consumer, a researcher, a journalist, or a business looking to understand the landscape, this resource is updated regularly with current market figures, consumer behaviour trends, and category-level breakdowns.
Last updated: July 2026.
Before zooming into supplements specifically, it helps to understand the broader wellness ecosystem in which they sit.
Australia ranks among the top ten wellness markets in the world. According to the Global Wellness Institute's 2025 Global Wellness Economy Monitor, the global wellness economy reached a new peak of USD 6.8 trillion in 2024, doubling in size since 2013. Australia is a standout performer within this picture. The GWI's dedicated Australia report, published in August 2025, confirmed that Australia's wellness economy grew at a rate of 7.5% annually from 2019 to 2023, with a particularly strong 10.9% jump recorded between 2022 and 2023 to reach USD 126.7 billion.
Australia ranks 10th globally for the size of its wellness economy, 7th globally for per capita wellness spending (USD 4,824 per person), and 4th in the Asia Pacific. In the GWI's January 2026 Country Rankings report, covering data from 145 countries, Australia was identified as one of the standout five-year growth leaders among the world's largest wellness markets, alongside the UAE, India, the UK, Canada, and the US.
The dietary supplement sector is one of the fastest-growing segments within that broader economy.

Estimates for the Australian dietary supplement market vary depending on scope and methodology, but the direction is consistent across all sources: strong, sustained upward growth.
Mordor Intelligence defines the market narrowly (discrete supplement products only) and values it at USD 1.97 billion in 2025, projected to reach USD 2.95 billion by 2030 at a CAGR of 8.33%.
IMARC Group uses a broader definition covering all dietary supplement products and places the 2025 market at USD 3.86 billion to USD 3.9 billion, with projections ranging from USD 7.2 billion to USD 8.04 billion by 2033 to 2035, depending on the forecast horizon. The CAGR under IMARC's methodology is approximately 7.02% to 7.62%.
Expert Market Research values the market at AUD 8.82 billion in 2025 (using a broader local currency measure), projecting growth to AUD 19.22 billion by 2035 at a CAGR of 8.10%.
When the scope expands to include all nutritional supplements, functional foods, and nutraceuticals, the figures grow considerably larger. IMARC estimates the overall nutritional supplements market reached USD 14.5 billion in 2025 and could reach USD 28.8 billion by 2034. Grand View Research puts the 2025 nutritional supplements figure at USD 15.5 billion, projecting USD 26.1 billion by 2033 at a 6.7% CAGR.
Mordor Intelligence estimates the total nutraceuticals market (functional foods, beverages, and dietary supplements combined) at USD 7.45 billion in 2025, growing to USD 9.52 billion by 2030 at a 5.04% CAGR.
The range reflects methodological differences, not disagreement. Every source points to the same conclusion: clear, sustained upward growth.
| Metric | Figure | Source |
|---|---|---|
| Dietary supplements market (2025, narrow) | USD 1.97 billion | Mordor Intelligence |
| Dietary supplements market (2025, broad) | USD 3.86-3.9 billion | IMARC Group |
| Dietary supplements market (2025, AUD) | AUD 8.82 billion | Expert Market Research |
| Dietary supplements CAGR (2026 to 2034) | 7.02% to 8.10% | IMARC / Expert Market Research |
| Nutritional supplements market (2025) | USD 14.5-15.5 billion | IMARC / Grand View Research |
| Nutraceuticals market (2025) | USD 7.45 billion | Mordor Intelligence |
| Total wellness economy, Australia (2023) | USD 126.7 billion | Global Wellness Institute |
| Global wellness economy (2024) | USD 6.8 trillion | Global Wellness Institute |
| Per capita wellness spend | USD 4,824/year | Global Wellness Institute |
| Australia global wellness rank | 10th globally, 4th in Asia Pacific | Global Wellness Institute |
The most authoritative source for supplement consumption data is the Australian Bureau of Statistics (ABS), which conducted its National Nutrition and Physical Activity Survey (NNPAS) from January 2023 to March 2024, with results published in September 2025.
The headline number: one in three Australians (33.6%, or approximately 8.5 million people) took a dietary supplement in 2023. This is a meaningful increase from 28.5% recorded in the 2011 to 2012 survey, reflecting genuine growth in supplement uptake over the past decade.
Key patterns from the ABS data include the following.
The gender gap is significant. Adult females are considerably more likely to take supplements than adult males, with 43.7% of women taking at least one supplement compared to 30.8% of men. This gap holds across all adult age groups.
Usage increases with age. Among adults, the proportion taking supplements rises from about one in four (24.5%) in the 18 to 29 age group to more than one in two (50.9%) among those aged 75 and over.
Vitamins and minerals dominate. Nearly three in ten Australians (29.7%) took a vitamin or mineral supplement in 2023, up from 21.9% in 2011 to 2012, making this the largest supplement category by a substantial margin.
Multivitamins and vitamin D lead individual categories. Multivitamin or multimineral use increased from 9.5% in 2011 to 2012 to 15.5% in 2023. Vitamin D supplementation grew from 3.5% to 9.3% over the same period, a near-tripling, partly driven by awareness of deficiency. The National Health Measures Survey 2022 to 2024 found that one in five Australian adults (20.6%) had a vitamin D deficiency.
When Euromonitor surveyed a broader sample in late 2024, they found a significantly higher overall rate, with nearly 74% of Australians reporting taking at least one supplement in the past year, and 41% saying they did so daily. The most commonly used categories were multivitamins (43%), vitamin D (35%), vitamin C (33%), probiotics (28%), and omega-3 or fish oils (26%).
The divergence between the ABS figure (33.6%) and the Euromonitor figure (74%) reflects different survey methodologies and definitions of "supplement." The ABS applies strict dietary supplement criteria from a rigorous national survey, while Euromonitor captures a self-reported broader spectrum. Both reflect the same trend: supplement use is common, growing, and increasingly normalised as part of everyday health management in Australia.
Vitamins and minerals account for the largest share of the dietary supplement market in Australia and New Zealand, representing 29.4% of the combined market as of 2024. Vitamin supplements hold close to 28% to 30% revenue share depending on the reporting period. This category includes vitamins C, D, B-complex, zinc, magnesium, and iron in formats ranging from traditional capsules and tablets through to gummies and powders.
Tablets remain the most popular delivery format, accounting for 31.6% to approximately 30% of the market by revenue. Gummies have seen rapid growth, particularly among younger consumers and parents supplementing children. Powders are the fastest-growing format by CAGR, driven by younger consumers integrating supplements into food and beverage routines such as morning smoothies and coffee stacks.
Consumer motivation for vitamin use is shifting toward prevention. Euromonitor data from early 2024 shows that close to 15% of Australians now believe vitamins and supplements are important to their overall health, up from just 9% in 2019. More than half (58%) of supplement users take products primarily to prevent illness or deficiency rather than manage a diagnosed condition.
One significant regulatory development affecting this category: from 1 June 2027, vitamin B6 supplements with a recommended daily dose of more than 50mg but 200mg or less will be reclassified as pharmacist-only (Schedule 3) medicines in Australia. Products providing more than 200mg per day will require a prescription. The TGA finalised this decision in November 2025 following a review of 250 adverse event reports of peripheral neuropathy linked to high-dose B6 products. Products containing 50mg or less per day remain available over the counter. Consumers who take multiple supplements should check their combined B6 intake across all products. Explore our range of Vitamin D supplements and Magnesium supplements.
Australia has a thriving sports nutrition and fitness culture, and protein supplements sit at the centre of it.
IMARC Group estimates the Australian protein supplements market reached USD 562.2 million in 2025, with projections of USD 1.03 billion by 2034 at a CAGR of 6.72%. Grand View Research notes that the proteins and amino acids segment is projected to be the fastest-growing supplement segment in the Australia and New Zealand market, with a CAGR of 13.9% from 2025 to 2030. In September 2025, industry retail data indicated a 14% year-on-year rise in online protein supplement sales across Australia, driven by subscription-based fitness programs and growing demand for ready-to-drink protein beverages among urban consumers.
Protein powders dominate, but protein bars and ready-to-drink formats are gaining ground. Whey protein remains the most widely used source, though it has faced pricing pressure: whey costs in Australia rose approximately 52% between August 2024 and December 2025 due to global dairy supply constraints.
Plant-based protein is the fastest-growing sub-segment. As more Australians shift toward flexitarian, vegetarian, and vegan eating, demand for pea, rice, and hemp-based proteins has grown consistently. There is also a clear movement toward multi-functional protein products: demand is growing for protein products enriched with probiotics, vitamins, collagen, and immunity boosters as consumers look for products that deliver multiple health benefits in a single serve.
Browse our range of Protein Powders, Whey Protein Isolate, and Vegan Protein Supplements.
Gut health has moved from a niche interest to a mainstream wellness priority, and the market data confirms it.
The Australian probiotics market was valued at USD 2.53 billion in 2024 and is projected to reach USD 5.12 billion by 2032 at a 9.3% CAGR, according to Credence Research. Fish oils and omega fatty acids and probiotic supplements are among the categories Euromonitor expects to see the most dynamic growth rates going forward, as heart health, brain function, and digestive health remain top priorities for Australian consumers.
The gut-brain connection is increasingly driving consumer interest. Awareness of how microbiome health relates to mood, energy, immunity, and inflammation has made probiotics a daily staple for a growing cohort of Australians. Probiotic formats are diversifying rapidly, with gummies, powders, and shelf-stable capsules joining traditional dairy-based sources. The prebiotic and probiotic foods market is growing even faster, with IMARC projecting this category could reach USD 9.89 billion by 2033.
A significant regulatory milestone: in July 2025, Clasado Biosciences received TGA approval to include its prebiotic ingredient Bimuno GOS in TGA-listed therapeutic products, allowing supplement formulators to develop products with recognised gut health claims backed by regulatory sign-off. In May 2025, Australian brand Biome Australia launched its new brand Activated Therapeutics, featuring products targeting perimenopause relief and gastrointestinal health, reflecting the growing convergence of clinical nutrition and gut health supplementation.
Explore our Probiotics and Gut Health Supplements.
Collagen is one of the fastest-growing supplement categories in Australia, occupying a unique position at the intersection of beauty, joint health, and general wellness.
The "beauty from within" movement has gained substantial momentum in 2025 and 2026. Collagen peptides, hyaluronic acid, biotin, and antioxidant-rich vitamins have become common ingredients in daily supplement regimens, appealing especially to female consumers and the ageing population. In March 2025, Australian brand Vincent entered the US market with a four-step beauty regimen combining skincare and a dietary supplement, targeting the growing demand for ingestible beauty products. The brand features activated phenolics extracted from Australian apples.
Bovine-sourced collagen currently represents the largest market share by source, but marine collagen is growing at a faster rate as sustainability-conscious consumers seek ethical alternatives. Collagen powders are commonly added to coffee, smoothies, and matcha drinks as part of morning wellness routines. Browse our Collagen Beauty Supplements.

Omega-3 supplements consistently rank among the top five most used supplement categories in Australia. Euromonitor's 2024 survey data found that approximately 26% of Australians used omega-3 or fish oil supplements in the prior year. Euromonitor projects omega-3 and probiotics to be among the most dynamically growing categories through 2026 and beyond, driven by ongoing awareness of cardiovascular, brain, joint, and inflammation benefits.
The TGA listing status of many omega-3 products provides Australian consumers with a meaningful baseline of quality assurance. Plant-based algae-derived omega-3 options are growing rapidly as vegan and sustainability-conscious consumers seek fish-free alternatives. Explore our full supplement range.
One of the most significant shifts in the Australian supplement market heading into 2026 is the mainstreaming of creatine beyond its traditional gym-goer audience. Globally, the creatine supplements market was valued at USD 1 billion in 2024 and is projected to reach USD 2.8 billion by 2030, growing at a CAGR of 17.9% (Grand View Research). Creatine is now appearing on ingredient watch lists for 2026 nutraceutical development, driven by a broadening evidence base that extends beyond sports performance to include cognitive function, healthy ageing, and muscle preservation during calorie restriction.
This last point is particularly relevant given the rise of GLP-1 weight-loss medications in Australia (covered below). Creatine is increasingly positioned as a companion supplement for GLP-1 users to maintain muscle mass during rapid weight loss. Browse our Creatine supplements.
The adaptogens and functional mushroom category has moved well beyond early-adopter wellness communities into mainstream Australian retail. Ashwagandha, lion's mane, reishi, and cordyceps are among the most searched supplement ingredients in 2025 and 2026. Ashwagandha in particular consistently appears on ingredient watch lists for 2026 nutraceutical development, driven by its evidence base around stress and anxiety support.
The global nootropic supplement market was valued at USD 2.3 billion in 2024 and is projected to reach USD 5 billion by 2034 at a CAGR of 7.8% (Global Market Insights). In Australia, cognitive health supplements are one of the fastest-growing niche categories, driven by increasing consumer awareness of the gut-brain axis and strong interest in focus, mood, and memory support.
Explore our Adaptogens, Mushroom Supplements, and Nootropics.
One of the biggest structural shifts affecting the Australian supplement market in 2025 and 2026 is the widespread uptake of GLP-1 receptor agonist medications, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro). Originally developed to treat type 2 diabetes, these medications are now widely prescribed for weight management across Australia, with the TGA reviewing oral semaglutide formulations approved in other markets for potential Australian listing.
The GLP-1 effect is creating a parallel growth opportunity for the supplement industry. People using these medications eat significantly less, which creates genuine nutritional gaps. The resulting demand for companion supplements targeting protein intake, muscle preservation, bone health, digestive comfort, and micronutrient coverage is a new and meaningful growth vector. Key supplements gaining traction in this context include creatine monohydrate (muscle preservation), collagen peptides (joint and connective tissue), magnesium (muscle function and energy), vitamin D and calcium (bone health during rapid weight loss), and probiotic and prebiotic products (to manage GLP-1-associated digestive changes such as slowed gastric emptying).
Separately, there is growing consumer interest in natural GLP-1 support: supplements containing berberine, soluble fibre, and specific probiotics are being positioned as metabolism-supportive alternatives for consumers who are not on GLP-1 medications but want to support satiety and blood sugar regulation through nutrition.
Supplement use does not exist in isolation. Many Australians who take supplements also actively seek out organic, clean-label foods, and the two categories reinforce each other at the consumer level.
The Australian organic food market reached USD 1.1 billion in 2024 and is projected to grow to USD 2.2 billion by 2033 at a CAGR of 7.49% (IMARC). Australia has over 53 million hectares of certified organic farming land, making it one of the largest organic production countries in the world by land area. Australian Certified Organic (ACO) is the dominant certifying body, covering 76% of farmers and producers and 74% of processors.
The top organic product categories by farming land are vegetables (29%), fruits (23%), wine grapes (21%), and beef (19%). Retail distribution for organic products has expanded significantly, with Woolworths and Coles widening their organic ranges and e-commerce lowering the barrier to access for consumers in regional areas. For shoppers interested in certified organic pantry staples, explore products from Anthony's Goods and our wider Organic collection.
The shift toward plant-based eating in Australia continues to create meaningful implications for supplement demand, particularly in categories like protein, B12, iron, omega-3, and vitamin D, where plant-forward diets can create nutritional gaps.
The ABS NNPAS 2023 found that 5.3% of Australians identify as vegetarian or vegan. Roy Morgan survey data puts the broader figure at approximately 2.5 million Australians (around 12.1% of adults) following diets that are entirely or mostly vegetarian or vegan. The 2024 Food Frontier Consumer Survey identified "meat reducer" as the most popular dietary choice in 2024, with 21% of Australians identifying in this category. While 51% of Australians still maintain their current level of meat consumption (down from 56% in 2021), a quarter of the population has actively reduced their intake.
The top three motivations for reducing meat are health benefits (61%), budget constraints (54%), and environmental concerns (37%). Around 34% of Australians now consume plant-based milks at least once a week, and 40% have tried lactose-free milk.
A person reducing animal foods from their diet needs to be more intentional about protein, B12, zinc, iron, and omega-3 intake, and supplements fill that gap. Explore our range of Vegan Protein Supplements.
The superfood and functional nutrition space continues to expand as the line between food and supplement blurs. Protein powders, greens blends, collagen powders, and meal replacements are increasingly incorporated into daily routines. Product innovation, including flavoured and plant-based options, continues to drive growth in powder formats across multiple categories.
Matcha remains one of the strongest superfood stories in Australia. The shift from specialty cafe product to mainstream home wellness staple is well established, appreciated for its L-theanine and caffeine combination producing calm, focused energy, as well as its antioxidant profile. Explore the Matcha collection at Wallaby Wellness.
Electrolyte and hydration supplements represent one of the faster-growing subcategories in functional nutrition. Post-pandemic awareness of hydration's role in energy, cognition, and recovery has expanded this category well beyond gym-goers into everyday health management. Explore Electrolyte supplements.
In 2026, functional beverages are evolving significantly. Consumer expectations have shifted toward products that deliver focus, immunity, and gut support alongside caffeine, driving demand for mushroom coffees, matcha-based drinks, and adaptogen-infused beverages. Explore our range of Functional Drinks and Superfoods and Functional Foods.
Sea moss, colostrum, NMN, and shilajit are among the specialty supplement categories experiencing the most rapid growth in Australian consumer interest through 2025 and 2026. Explore our Sea Moss Supplements, Colostrum Supplements, NMN Supplements, and Shilajit.
Women are the dominant buyers. Roy Morgan data found that 4.88 million Australian women (46% of the female population) buy vitamins, minerals, or supplements in any given six-month period, compared to 3.36 million men (33%). Over 45% of women aged 25 and over buy these products, rising to 50% or more for women aged 35 to 64.
Peak buying ages are 35 to 64. This cohort is the core market for most supplement categories, driven by disposable income, health awareness, and the onset of age-related concerns around energy, joints, hormonal health, and immunity.
Women's health is undergoing a major recalibration. The GWS 2026 Future of Wellness Trends report highlights that women are now being provided with dedicated, evidence-based approaches to longevity, recovery, and sports performance, rather than being treated as adaptations of male-centric models. Supplementation targeted at perimenopause, menopause, and healthy ageing is one of the fastest-growing sub-segments in the Australian women's health supplement market. In 2025, Biome Australia's Activated Therapeutics launched products specifically targeting perimenopause relief, a sign of how mainstream this category is becoming. Explore our Women's Health Supplements and Menopause Supplements.
Prevention is the primary motivation. More than half (58%) of supplement users in Australia take products primarily for prevention rather than treatment. A further 24% use supplements to manage a diagnosed condition. This reflects a genuine cultural shift toward proactive health management rather than reactive treatment.
Prenatal health is the fastest-growing end-use segment. Grand View Research identifies prenatal health as the fastest-growing CAGR segment in the Australia and New Zealand dietary supplements market from 2025 to 2030, fuelled by growing awareness of maternal and fetal nutrition and increasing healthcare professional recommendations for folic acid, iron, and DHA during pregnancy.
Adults remain the dominant end-use segment, accounting for 62.6% of the Australia and New Zealand market in 2024, driven by stress, poor dietary habits, sedentary routines, and strong demand for immunity, energy, and heart health products.
The distribution landscape for supplements has shifted significantly over the past five years.
Offline channels, pharmacies, supermarkets, and health food stores, still lead in overall market share, driven by consumer preference for in-store guidance and the ability to physically inspect products. However, online retail is the fastest-growing distribution channel by CAGR. Rising internet penetration, breadth of product range online, competitive pricing, and the lasting behavioural changes from COVID-19 have all contributed. For specialty health food retailers like Wallaby Wellness, the online channel offers a meaningful opportunity to reach health-conscious consumers nationally, including those in regional areas with limited access to specialist stores.
OTC (over-the-counter) supplements accounted for approximately 75% of revenue share in the historical period, reflecting strong consumer preference for self-directed supplementation. The shift toward online OTC purchasing is particularly pronounced among younger consumers aged 18 to 34, who are more comfortable researching and purchasing supplements directly via e-commerce.
Australia's regulatory framework is one of the factors that distinguishes its supplement market internationally. Dietary supplements are classified as listed medicines and regulated by the Therapeutic Goods Administration (TGA), which requires products to meet safety and quality standards before they can be sold. TGA-listed products display an "AUST L" number on their label.
Key regulatory developments through 2025 and 2026 include the following.
Vitamin B6 rescheduling (effective June 2027). Following a review of 250 adverse event reports of peripheral neuropathy associated with high-dose vitamin B6, the TGA confirmed in November 2025 that products with a recommended daily dose of more than 50mg but 200mg or less will be reclassified as Schedule 3 (pharmacist-only) medicines, effective 1 June 2027. Products with more than 200mg per day will become Schedule 4 (prescription required). Products containing 50mg or less per day remain available for general sale. This affects 116 currently listed products. Consumers taking multiple supplements should audit their total daily B6 intake.
Bimuno GOS approved (July 2025). Clasado Biosciences received TGA approval to include its prebiotic ingredient Bimuno GOS in TGA-listed therapeutic products, allowing formulators to develop supplements with recognised gut health claims. This reflects the TGA's growing engagement with functional prebiotic applications.
Labelling strengthening proposal (May 2024). The TGA unveiled a proposal to strengthen labelling requirements for listed medicines sold in large oral formats, particularly oversized tablets and capsules that may pose a choking hazard. This reflects ongoing TGA efforts to improve consumer safety information at the product level.
NHMRC B6 upper limit review. The National Health and Medical Research Council (NHMRC) is also reviewing the Upper Limits for vitamin B6, expected to be completed by early 2027. This will inform any further changes to retail availability.
The personalised nutrition market in Australia was valued at USD 359.5 million in 2024 and is projected to grow to USD 853.5 million by 2030. AI-powered algorithms, at-home testing kits, and the integration of wearable device data with nutrition apps are enabling a new generation of precision supplement recommendations tailored to genetic profile, lifestyle, and biometric data. The 2026 wellness trend forecast from the Global Wellness Summit identifies precision wellness as one of the defining movements of the year, with consumers moving from one-size-fits-all health solutions to proactively tailored approaches.
The mood and relaxation supplement category was the fastest-growing segment in the Australian vitamin and dietary supplement market between 2019 and 2024. With 31% of Australians identifying stress or anxiety among their top three health priorities, the demand for supplements targeting mood, sleep, and cognitive function remains substantial. The estimated economic cost of poor sleep in Australia is AUD 66.3 billion per year, creating a clear consumer pain point the supplement industry continues to address. Explore our Sleep Supplements and Stress and Anxiety Supplements.
Australia's ageing demographic is creating sustained demand for supplements targeting joint health, cognitive support, and longevity. Approximately 2.1 million Australians were living with osteoarthritis in 2022 (AIHW). A December 2024 RACGP report found that Australians lost approximately 5.8 million years of healthy life to disease and premature death in 2024, with overweight and obesity the leading risk factor at 8.3%, surpassing tobacco use and poor diet.
The 2026 Global Wellness Summit Trends report identifies longevity as expanding beyond supplements and clinics into real estate and urban design, as environments are increasingly designed to support long-term physical, cognitive, and social health. Within supplements, NMN, collagen, adaptogens, and functional mushrooms are among the longevity-oriented categories growing fastest. Explore our Longevity collection and NMN Supplements.
As covered above, the widespread adoption of GLP-1 medications in Australia is creating a new companion nutrition market. Consumers on GLP-1 medications are eating significantly less and need targeted supplements to maintain muscle mass, bone health, micronutrient coverage, and digestive comfort. Key ingredients gaining traction in this context include creatine, protein, collagen, magnesium, vitamin D, and specific probiotic strains.
Australian consumers are increasingly scrutinising ingredient lists. The preference for supplements free from artificial colours, preservatives, and synthetic fillers, with a corresponding rise in demand for certified organic, non-GMO, and allergen-free options, continues to intensify in 2025 and 2026. This clean label movement is pushing brands toward greater transparency and simpler formulations. It is also driving demand for products with TGA listing, certified organic status, and third-party testing as markers of quality assurance.
Women's health supplementation is no longer a sub-segment within general wellness. In 2026, it is a distinct category with its own formulation language, life-stage focus, and consumer expectations. Perimenopause relief, cycle support, bone density, and longevity are among the fastest-growing areas. The GWS 2026 Trends report explicitly notes that women are now receiving dedicated, evidence-based wellness solutions across sport, recovery, and ageing, representing a long-overdue correction to the historical male bias in nutritional research and product development. Explore our Women's Health Supplements and Hormone Balance Supplements.
Australia represents approximately 2.6% to 3.0% of the global dietary supplement market's total revenue. While this is a small absolute share, it is large relative to a population of around 26 million, reflecting Australians' high per capita wellness spending and strong supplement culture.
Australia is named as one of the standout five-year growth leaders in the GWI's January 2026 Country Rankings, alongside the UAE, India, the UK, Canada, and the US, among the world's largest wellness markets. Australian brands, including Blackmores, Swisse, Life-Space Probiotics, and Remedy Drinks, have significant international reach, particularly across Asia, where demand for Australian-manufactured supplements is strong due to perceived quality and clean provenance.
The country is also a meaningful innovation hub. In 2025, Biome Australia launched Activated Therapeutics with clinical-grade gut health products. Australian brand Vincent entered the US market with an ingestible beauty supplement range. Vitadrop, co-founded in Australia, launched 11 TGA-accredited water-based vitamin supplement products in early 2024. These launches reflect Australia's growing role as an originator of supplement innovation with global ambitions.
| Statistic | Figure |
|---|---|
| Dietary supplements market (2025, broad) | USD 3.86-3.9 billion |
| Dietary supplements market (2025, AUD) | AUD 8.82 billion |
| Dietary supplements CAGR (2026 to 2034/35) | 7.02% to 8.10% |
| Nutritional supplements market (2025) | USD 14.5-15.5 billion |
| Nutraceuticals market (2025) | USD 7.45 billion |
| Protein supplements market (2025) | USD 562.2 million |
| Probiotics market (2024) | USD 2.53 billion |
| Organic food market (2024) | USD 1.1 billion |
| Australians taking supplements (2023, ABS) | 33.6% (8.5 million people) |
| Daily supplement users | ~41% of supplement users |
| Women taking supplements | 43.7% of adult females |
| Most used supplement category | Vitamins and minerals (29.7%) |
| Adults segment share (ANZ market, 2024) | 62.6% |
| Fastest-growing end-use segment | Prenatal health |
| Fastest-growing ingredient segment | Proteins and amino acids (13.9% CAGR) |
| Plant-based diet identifiers | 5.3% to 12.1% depending on definition |
| Meat reducers (2024) | 21% of Australians |
| Total wellness economy, Australia (2023) | USD 126.7 billion |
| Global wellness economy (2024) | USD 6.8 trillion |
| Per capita wellness spend | USD 4,824/year |
| Australia global wellness rank | 10th globally, 4th in Asia Pacific |
| Personalised nutrition market (2024) | USD 359.5 million |
| Creatine global market CAGR (to 2030) | 17.9% |
This article draws on research from the following sources. All market size figures and projections should be understood as estimates by the respective research organisations, using their own methodologies and data collection approaches. Figures vary between organisations based on scope and definition.
This page is updated regularly. Last updated: July 2026. If you notice a data point that has changed or a significant new study, please contact us at [email protected].